Article Text

Download PDFPDF

P147 The changing shape of patients with idiopathic pulmonary fibrosis
Free
  1. RL Wollerton1,
  2. CJ Scotton1,
  3. MA Gibbons2
  1. 1University of Exeter, Exeter, UK
  2. 2Royal Devon and Exeter Hospital, Exeter, UK

Abstract

Background Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible and ultimately fatal disease. An association between diabetes, obesity and IPF has previously been demonstrated.1 Decreasing body mass index (BMI) is predictive of worse survival in Japanese cohorts.2

Objective To investigate the metabolic characteristics in our cohort of IPF patients (South West Peninsula, England) receiving anti-fibrotic therapy (nintedanib or pirfenidone), observe how BMI changes over time and relationships with changes in forced vital capacity (FVC) and survival.

Method Data was collected from IPF patients at the Regional Exeter ILD Centre at diagnosis (age, gender, FVC, BMI, co-morbidities) and subsequent appointments (FVC and BMI). Change between BMI/FVC at diagnosis and most recent BMI/FVC were calculated and standardised to time elapsed between data points (DBMI or DFVC respectively). National data were from Public Health England (2014 datasets).

Results We reviewed 90 patients receiving antifibrotics. 76 were male (84%), mean age was 74. Their co-morbidities are illustrated by Table 1. Type 2 diabetes mellitus affected 14 patients (16%), compared with 12% in the age-adjusted general population. Recent BMIs were available for 46 patients. 10 patients (20%) had a normal BMI 18.5–24.99 (compared with a national average of 37%). Mean BMI (28.3) was significantly increased above the national average (27.3; p<0.05 one-tailed t-test). Pearson correlation coefficient for change in BMI and survival was r=−0.55, 95% confidence interval −0.90 to 0.25 (8 patients). Where DBMI and DFVC were temporally overlapping (19 patients), no correlation was found.

Abstract P147 Table 1

Characteristics of the exeter IPF cohort (SD=standard deviation)

Conclusions A large proportion of our IPF cohort were classified as obese. Diabetes was a common comorbidity, and higher than the national average. Over time, most patients demonstrated a reduction in their BMI. In contrast to East Asian data, this reduction in BMI did not correlate with reduction in FVC or survival.

References

  1. Kim YJ, Park J-W, Kyung Y, et al. Association of diabetes mellitus and metabolic syndrome with idiopathic pulmonary fibrosis. Tuberc Respir Dis2009;67:113–120.

  2. Kishaba T, Nagano H, Nei Y, et al. Body mass index—percent forced vital capacity—respiratory hospitalisation: New staging for idiopathic pulmonary fibrosis patients. J Thorac Dis2016;8(12):3596–3604.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.